These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Rad51 recruitment and exclusion of non-homologous end joining during homologous recombination at a Tus/Ter mammalian replication fork barrier. Willis NA; Panday A; Duffey EE; Scully R PLoS Genet; 2018 Jul; 14(7):e1007486. PubMed ID: 30024881 [TBL] [Abstract][Full Text] [Related]
43. Role and regulation of human XRCC4-like factor/cernunnos. Dahm K J Cell Biochem; 2008 Aug; 104(5):1534-40. PubMed ID: 18335491 [TBL] [Abstract][Full Text] [Related]
44. XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair. Mahaney BL; Hammel M; Meek K; Tainer JA; Lees-Miller SP Biochem Cell Biol; 2013 Feb; 91(1):31-41. PubMed ID: 23442139 [TBL] [Abstract][Full Text] [Related]
45. A novel small molecule inhibitor of the DNA repair protein Ku70/80. Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816 [TBL] [Abstract][Full Text] [Related]
46. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. IJspeert H; Rozmus J; Schwarz K; Warren RL; van Zessen D; Holt RA; Pico-Knijnenburg I; Simons E; Jerchel I; Wawer A; Lorenz M; Patıroğlu T; Akar HH; Leite R; Verkaik NS; Stubbs AP; van Gent DC; van Dongen JJ; van der Burg M Blood; 2016 Aug; 128(5):650-9. PubMed ID: 27281794 [TBL] [Abstract][Full Text] [Related]
47. A role for XLF in DNA repair and recombination in human somatic cells. Fattah FJ; Kweon J; Wang Y; Lee EH; Kan Y; Lichter N; Weisensel N; Hendrickson EA DNA Repair (Amst); 2014 Mar; 15():39-53. PubMed ID: 24461734 [TBL] [Abstract][Full Text] [Related]
48. Akt-mediated phosphorylation of XLF impairs non-homologous end-joining DNA repair. Liu P; Gan W; Guo C; Xie A; Gao D; Guo J; Zhang J; Willis N; Su A; Asara JM; Scully R; Wei W Mol Cell; 2015 Feb; 57(4):648-661. PubMed ID: 25661488 [TBL] [Abstract][Full Text] [Related]
49. IgH class switching and translocations use a robust non-classical end-joining pathway. Yan CT; Boboila C; Souza EK; Franco S; Hickernell TR; Murphy M; Gumaste S; Geyer M; Zarrin AA; Manis JP; Rajewsky K; Alt FW Nature; 2007 Sep; 449(7161):478-82. PubMed ID: 17713479 [TBL] [Abstract][Full Text] [Related]
50. Ku recruits XLF to DNA double-strand breaks. Yano K; Morotomi-Yano K; Wang SY; Uematsu N; Lee KJ; Asaithamby A; Weterings E; Chen DJ EMBO Rep; 2008 Jan; 9(1):91-6. PubMed ID: 18064046 [TBL] [Abstract][Full Text] [Related]
51. Functional significance of the interaction with Ku in DNA double-strand break recognition of XLF. Yano K; Morotomi-Yano K; Lee KJ; Chen DJ FEBS Lett; 2011 Mar; 585(6):841-6. PubMed ID: 21349273 [TBL] [Abstract][Full Text] [Related]
52. Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and nonhomologous DNA end joining. Oksenych V; Kumar V; Liu X; Guo C; Schwer B; Zha S; Alt FW Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2234-9. PubMed ID: 23345432 [TBL] [Abstract][Full Text] [Related]
53. Phosphorylation of Ku dictates DNA double-strand break (DSB) repair pathway choice in S phase. Lee KJ; Saha J; Sun J; Fattah KR; Wang SC; Jakob B; Chi L; Wang SY; Taucher-Scholz G; Davis AJ; Chen DJ Nucleic Acids Res; 2016 Feb; 44(4):1732-45. PubMed ID: 26712563 [TBL] [Abstract][Full Text] [Related]
54. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance. Yang S; Wang XQ BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069 [TBL] [Abstract][Full Text] [Related]
55. Role of Paralogue of XRCC4 and XLF in DNA Damage Repair and Cancer Development. Tang J; Li Z; Wu Q; Irfan M; Li W; Liu X Front Immunol; 2022; 13():852453. PubMed ID: 35309348 [TBL] [Abstract][Full Text] [Related]
56. [Non-homologous DNA end joining--new proteins, new functions, new mechanisms]. Popławski T; Stoczyńska E; Błasiak J Postepy Biochem; 2009; 55(1):36-45. PubMed ID: 19514464 [TBL] [Abstract][Full Text] [Related]
57. Microhomology-mediated end joining: Good, bad and ugly. Seol JH; Shim EY; Lee SE Mutat Res; 2018 May; 809():81-87. PubMed ID: 28754468 [TBL] [Abstract][Full Text] [Related]
58. The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV. Kuhfittig-Kulle S; Feldmann E; Odersky A; Kuliczkowska A; Goedecke W; Eggert A; Pfeiffer P Mutagenesis; 2007 May; 22(3):217-33. PubMed ID: 17347130 [TBL] [Abstract][Full Text] [Related]
59. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Li G; Alt FW; Cheng HL; Brush JW; Goff PH; Murphy MM; Franco S; Zhang Y; Zha S Mol Cell; 2008 Sep; 31(5):631-40. PubMed ID: 18775323 [TBL] [Abstract][Full Text] [Related]
60. PAXX and Xlf interplay revealed by impaired CNS development and immunodeficiency of double KO mice. Abramowski V; Etienne O; Elsaid R; Yang J; Berland A; Kermasson L; Roch B; Musilli S; Moussu JP; Lipson-Ruffert K; Revy P; Cumano A; Boussin FD; de Villartay JP Cell Death Differ; 2018 Feb; 25(2):444-452. PubMed ID: 29077092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]